GI 9, (13-15) , (49-54) Flashcards

1
Q

Meconium voiding

A

Initial physiological weight loss on the 3rd-4th day after birth due to meconium voiding, hunger, dehydration

max 10% of birth weight, regained after 10th day
150-250g/week increase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

meconium ileus what is it

A

Failure to pass the first stool in neonates (usually passes within the first 24-48h after birth)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

meconium ileus etiology

A

Etiology: 90% caused by cystic fibrosis

can also be Hirschprungs disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical presentation of meconium ileus

A

signs of a distal small bowel obstruction (thick meconium plugs the distal ileum)
Bilious vomiting
Abdominal distention
No passing of meconium or stool

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

diagnostics in meconium ileus

specific signs seen??

A

X-ray abdomen (with contrast agent)
* Dilated small bowel loops
* Microcolon: narrow caliber of the colon, as it is still unused (meconium has not been passed through yet)
* Neuhauser sign (soap bubble appearance): bubble-like appearance in the distal ileum and/or cecum as a result of meconium mixing with swallowed air
* Air-fluid levels are uncommon because of the viscous consistency of meconium. (missing air fluid level)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Treatment of meconium ileus

A
  • Enema with contrast agent, irrigoscopy (colon x-ray with contrast)
  • Surgery is required in complicated cases (eg perforation, volvulus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Intestinal atresia - what is it

A

Congenital defect that can occur at any point along the GI tract leading to complete (atresia) or incomplete (stenosis) occlusion of the affected lumen
often associated with chromosomal anomalies (eg. Down syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical presentation- Intestinal atresia

A
  • Intrauterine: Polyhydramios (excess of amniotic fluid during gestation)
  • Postpartum: signs of intestinal obstuction
    *abdominal distension
    *Bilious vomiting
    *Failed or delayed meconium passage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Epidemiology Intestinal atresia

A

approx. 7:10,000 live births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Intestinal atresia etiology

A

Often associated with chromosomal anomalies eg. Down syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Common types of intestinal atresia

A
  • dudenal atresia
  • jejuno-ileal atresia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnosis of intestinal atresia

A

◦ Prenatal Ultrasound
◦ Abdominal X-ray: Double-bubble sign (stomach and duodenum contains air in duodenal atresia), dilated bowel loops
◦ Evaluation for associated anomalies
* echocardiogram,
* US of brain/abdomen/spine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment of intestinal atresia

A
  • Preoperative:
    *placement of gastric tube for suction,
    *parenteral nutrition
    *fluid replacement
  • Surgery: bypass of the atresia or stenosis, possible to start with stoma to let dilated
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pyloric stenosis - pathogenesis

A

Hypertrophy and hyperplasia of the pyloric sphincter in the first months of life
*Most common cause of gastric outlet obstruction in infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Pyloric stenosis- epidemiology

A

0,5-5:1000 live births, boys > girls

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Pyloric stenosis etiology

A
  • Environmental factors:
    *exposure to nicotine during pregnancy
    *bottle feeding (drink more milk in less time —> pylorus muscle hypertrophy through overstimulation)
  • Genetic factors: increased risk with affected relatives
  • Macrolide antibiotics is associated with higher risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pyloric stenosis - clinical presentation develop at what age

A

Develop usually btw 2nd-7th week of age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Pyloric stenosis - clinical presentation

A
  • Frequent regurgitation progressing to projectile, nonbilious vomiting after feeding
  • Enlarged, thickened, olive-shaped, no tender pylorus should be palpable in the epigastrium
  • “Hungry vomiter”: demands re-feeding after vomiting
  • If left untreated —> dehydration, weight loss, failure to thrive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Pyloric stenosis diagnosis

A
  • Abdominal US: elongated and thickened pylorus
  • Barium studies: narrow pyloric orifice, Beak sign (dilation of stomach + narrowing at pylorus)
  • Endoscopy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Pyloric stenosis treatment

A
  • Conservative therapy before surgery:
    *correct electrolyte imbalance,
    *IV resuscitation,
    *frequent administration of small meals, *elevate head
  • Surgery: Ramstedt pyloromyotomy (longitudinal muscle-splitting incision of the hypertrophic sphincter)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Diaphragmatic hernia- pathogenesis

A

Protrusion of intra-abdominal contents into thorax through an abnormal opening in the diaphragm

  • Congenital (developmental defect, infants)
    *Congenital diaphragmatic hernias (CDH) are common developmental defects from incomplete fusion of embryonic components of the diaphragm
    or
  • acquired (from trauma/injury, adults)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Types of diaphragmatic hernia

A
  • Left-sided postero-lateral diaphragmatic defects: Bochdalek hernias (most common)
  • Anterior defects: Morgagni hernias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

50% of infants have additional conformational malformations in which congenital anomaly

A

diaphragmatic hernia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

diaphragmatic hernia clinical presentation

A
  • Postnatal presentation of respiratory distress + absent breath sounds —> due to
    *severe pulmonary hypoplasia,
    *persistent pulmonary hypertension of the newborn (PPHN),
    *poor surfactant production
  • Respiratory distress is the cause of high mortality, NOT the hernia itself
  • Auscultation of bowel sounds in the chest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Diagnosis of Diaphragmatic hernia

A
  • Antenatal US:
    *fluid-filled stomach/bowel seen in thorax, *peristalsis in chest (fetal endoscopy)
  • Chest x-ray:
    *abdominal contents
    *+ air/fluid-filled bowel
    *+ poorly aerated lung in thorax
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Treatment of Diaphragmatic hernia

A
  • Prenatal therapy:
    *antenatal glucocorticoids,
    *in utero surgery in selected cases
  • Postnatal therapy:
    *correction of hypoxia,
    *surfactant administration,
    *gastric suction,
    *surgery when stable
    Gentle ventilation in newborn! (Prevent bronchopulmonary dysplasia)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Intussusception

A

When a proximal part of the bowel invaginates into distal part of *
bowel —> mechanical obstruction + ischemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

what age group intussusception is common

A

Infants aged 3–24 months are most commonly affected, usually with no identifiable underlying cause.

more common in males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

most common causes of bowel obstruction in children

A

Intussusception,
incarcerated hernia,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Intussusception etiology

A
  • Mostly idiopathic 75% ( common in 3m-5yr old)
  • Pathological lead points:
    *intraperitoneal anomalies or abnormalities that obstruct or tether the bowel and act as lead points in the process of intussusception
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

intraperitoneal anomalies or abnormalities that obstruct or tether the bowel and act as lead points in the process of intussusception examples

A
  • **Meckel diverticulum **(most common in children)
  • Intestinal polyps or other benign tumors (most common in adults and 2nd most common in general)
  • Enlarged Peyer patches: individuals with a history of a recent viral infection or immunization (e.g., rotavirus or adenovirus)
    *** Bowel wall thickening in IgA vasculitis
  • Cystic fibrosis**
  • Hematoma, hemangioma
  • Enlarged lymph nodes, lymphomas
  • Adhesions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

pathophysiology of intussusception

A

Imbalance in the bowel wall (idiopathic or via a pathological lead point) → invagination or “telescoping” of a portion of intestinal bowel (intussusceptum) into the distal adjacent bowel loop (intussuscipiens)
→ impaired lymphatic drainage and increasing pressure in intussusceptum bowel wall
→ venous impairment
→ mesenteric vessels congestion
→ ischemia of intussusceptum bowel wall
→ sloughing of bowel mucosa (most sensitive to bowel ischemia since it is the furthest from the arterial supply)
→ transmural necrosis and perforation with prolonged ischemia
dysfunctional passage leads to mechanical bowel obstruction → vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

most common site for intussusception

A

Ileocecal invagination (most common; accounts for 85–90% of cases)

Ileoileal invagination
Ileocolic invagination
Colosigmoidal invagination
Appendicocecal invagination (very rare)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

symptoms of intussusception

A
  • Periodic colicky cramping abdominal pain
  • Currant jelly” bloody stool (mixture of blood and mucus)
  • Sausage-shaped mass in the RUQ, retraction in RLQ
  • High pitched bowel sounds on auscultation
  • Lethargy , pallor, and other symptoms of shock or altered mental status may be present.
  • Vomiting (initially nonbilious)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

diagnosis of intussusception

  • specific signs seen on US
A

If clinical suspicion is high —> perform an enema ◦
If diagnosis is unclear —> perform an US or abdominal X-ray

  • Abdominal US: ‣
    *Target sign: invaginated portion of bowel appears as rings on a target in transverse view)
    *Pseudokidney sign: lead point of invagination resembles a kidney
  • Contrast or air enema:
    *Interruption of contrast or air at site of invagination *
  • Abdominal x-ray: ‣
    *Inhomogenous distribution of gas with absence of air at the site of invagination
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

intussusception treatment

A
  • Initial step: nasogastric decompression and fluid resuscitation
  • Nonsurgical management: performed under continuous US or fluoroscopy guidance ◦
    *Air enema, hydrostatic reduction ‣
  • Surgical reduction: when pathological lead point is suspected, failed conservative treatment, ◦
    suspected gangrenous or perforated bowel, critically ill patient
    *Hutchinson maneuver (manual proximal bowel compression and reduction),
    resection + end- to-end anastomoses (for necrotic segments)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Volvulus

A

Twisting of a loop of bowel on its mesentery *
One of the most common causes of intestinal obstruction *
Almost always present as a midgut volvulus secondary to intestinal malrotation

Intestinal malrotation: arrest in normal rotation of the gut in utero, resulting in abnormal orientation
of the bowel and mesentery within the abdominal cavity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Intestinal malrotation:

A

arrest in normal rotation of the gut in utero, resulting in abnormal orientation
of the bowel and mesentery within the abdominal cavity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

volvulus typical age group and location

A

Effects neonates and infants (sigmoid volvulus usually affects adults)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

symptoms of volvulus

A
  • Bilious vomiting with abdominal distension in a neonate/infant
  • Abdominal pain, inability to pass nasogastric tube
  • Signs of bowel ischemia: hematochezia, hematemesis, hypotension, tachycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Diagnosis of volvulus

A
  • Barium swallow test: duodenal obstruction, corkscrew duodenum ◦
  • Barium enema: bird’s beak sign ◦
  • Abdominal US: whirlpool sign (color doppler) ◦
  • Abdominal x-ray: often normal, but can demonstrate bowel perforation —> air above diaphragm ◦

Lab:
* Metabolic alkalosis + hypokalemia (from vomiting)
* Neutrophilic leukocytosis + metabolic acidosis + elevated serum lactate (from bowel ischemia/
necrosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

treatment of volvulus

A
  • Initial resuscitation: NPO, nasogastric tube insertion, IV fluids, electrolytes, broad-spectrum IV AB
  • Emergency surgery! Urgent operation is necessary
    Short bowel syndrome from surgery —> parenteral feed, but die at early age
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Incarcerated hernia

A

Type of hernia in which the contents of the hernial sac cannot return back through the abdominal wall *
defect into the peritoneal cavity with the application of gentle external pressure

Increased risk of strangulation and bowel obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Appendicitis

A

Inflammation of the appendix, typically due to an obstruction of the appendiceal lumen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Etiology of appendicitis

A

Caused by obstruction of the appendiceal lumen due to:
1. Lymphoid tissue hyperplasia (60% of cases): most common cause in children and young adults
2. Appendiceal fecalith and fecal stasis (35% of cases): most common cause in adults
3. Neoplasm (uncommon): more likely in patients > 50 years of age [4]
4. Parasitic infestation (uncommon): e.g., Enterobius vermicularis, Ascaris lumbricoides, and species of the Taenia and Schistosoma gener

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

peak incidence of appendicitis

A

10-19 years of age
Lifetime risk= 8%
more common in males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

symptoms of appendicitis

A
  • Reliability of signs and symptoms in children is lower
  • Most reliable: emesis, duration of pain, abdominal tenderness, pain with walking/jumping/coughing, ◦
    fever, RLQ pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

diagnosis of appendicitis

A
  • Lab: CRP ≥ 10 mg/mL, WBC count > 16,000/mL
  • Pediatric appendicitis score: estimates likelihood of appendicitis in patients 3-18 years of age
  • Ultrasound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

treatment of appendicitis

A
  • Supportive care: NPO (bowel rest), IV fluids, electrolyte imbalance resuscitation, antiemetics, ◦
    antipyretics
  • Empiric antibiotic therapy in all patients with acute appendicitis ◦
  • Surgery: appendectomy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

what disease does appendectomy protect from?

A

Ulcerative colitis ( also smoking protects from it too )

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

Obstipation

A

complete inability to pass stool or gas)

Caused by some type of bowel obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

types of bowel obstruction

A
  • Congenital intestinal atresia (eg duodenal atresia, jejunal atresia)
  • Intussusception (eg secondary to Meckel diverticulum)
  • Congenital strictures and bands (eg Ladd bands (abnormal fibrous tissue attaching cecum to
    peritoneum and liver) in intestinal malrotation)
  • Hirschsprung disease
  • Meconium ileus
  • Rectal atresia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

Associated symptoms of obstipation

A

abdominal pain,
vomiting,
abdominal distension,
decreased bowel sounds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

Hirschsprung disease (congenital aganglionic megacolon)

A

Inherited disorder primarily affecting newborns
1 in 5000 live births

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

associated diseases with hirschprung disease

A

Down syndrome,
multiple endocrine neoplasia type 2 (MEN2), Waardenburg syndrome,
neuroblastoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

Pathophysiology of Hirschsprung
disease

A

Hirschsprung disease is caused by defective caudal migration of parasympathetic neuroblasts (precursors of ganglion cells) from the neural crest to the distal colon.
This process takes place between the 4th and 7th week of development.
Affected segments are histologically characterized by the absence of the Meissner plexus and Auerbach plexus (submucosal and myenteric plexus ganglion) beginning at the anorectal line, leading to:
* Inability of the myenteric plexus to control the intestinal wall muscles → uncoordinated peristalsis and slowed motility
* Spastic contraction of intestinal muscles → stenosis and functional obstruction
* Expansion of the colon segment proximal to the aganglionic section (possible megacolon)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

Extent of the disease Hirschsprung disease

A
  • Ultra-short segment: limited to the distal rectum below the pelvic floor and the anus
  • Short-segment: limited to the rectosigmoid region (approx. 80% of cases)
  • Long-segment: involvement of the distal colon up to the splenic flexure (approx. 10% of cases)
  • Total colonic: entire colon (3–8% of cases)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

early clinical presentation of hirschsprung disease

A

Early presentation:
delayed passage of meconium (>48h),
abdominal distension,
bilious vomiting,
tight anal sphincter, empty rectum, squirt sign (explosive release of stool and air upon removal of the finger),
palpation of feces via the abdominal wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Late presentation of hirschprungs disease

A

chronic constipation,
inability to pass gas,
failure to thrive/poor feeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

Hirschsprung disease (congenital aganglionic megacolon) diagnosis

A
  • Abdominal x-ray: decreased or absent air in rectum, dilated colon segment, distal intestinal
    obstruction
  • Barium enema: change in caliber in affected intestinal segment, retention of barium for 24-48h
  • Anorectal manometry: absent relaxation reflex of internal sphincter after stretching of rectum
    Measures the relaxation pressure of the internal anal sphincter after distension with a balloon ‣
    (difficult to perform in newborns)
  • Rectal biopsy: absence of ganglion cells, elevated ACh activity, hyperplasia of parasymp fibers ◦
    Confirmatory test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

Hirschsprung disease (congenital aganglionic megacolon) treatment

A
  • Surgical treatment ◦
    *Definitive treatment to remove the affected segment of the colon and bring the normal ‣
    ganglionic intestinal ends together
  • Pharmacological treatment
    Fluid resuscitation, nasogastric decompression, antibiotics if indicated, colonic irrigation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

malabsorption classification

A
  • impaired intraluminal digestion
  • Intestinal malabsorption
  • Malabsorption due to fermentation (maldigestion of carbohydrates)

In many cases more factors elicit the malabsorption (eg bacterial overgrowth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

Impaired intraluminal digestion *
Etiology

A
  • cystic fibrosis,
  • Schwachman syndrome,
  • isolated lipase or co-lipase deficiency,
  • impaired bile acid synthesis,
  • bile duct atresia (commonly in neonatal period),
  • interrupted enterohepatic circulation (ileal resection,
  • Crohn’s disease = malabsorption + maldigestion,
  • congenital malabsorption of bile acids),
  • congenital trypsinogen or enterokinase deficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

Intestinal malabsorption *
Etiology:

A
  • celiac disease,
  • sensitization to food proteins (cow’s milk, soy, rice, wheat),
  • Giardia infection,
  • postenteritis syndrome,
  • immunodeficiency syndromes,
  • acrodermatitis enteropathica,
  • bacterial overgrowth,
  • Crohn’s disease,
  • short bowel syndrome,
  • intestinal lymphangiectasia,
  • autoimmune enteropathy,
  • congenital microvillus atrophy,
  • selective transport defects
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

Malabsorption due to fermentation

A

Disaccharide deficiencies
* Lactose (congenital, secondary, adult)
* Sucrose (congenital, secondary)
* Isomaltoze (congenital, secondary)’

Monosaccharidde malabsorptions ◦
* Glucose/galactose
* Fructose (toddler’s diarrhea —> usually grow out of it)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

Malabsorption due to fermentation primary forms vs secondary

A

In primary forms the small intestines has normal structure (due to an enzyme deficiency),
in secondary form the small intestines are damaged

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

Celiac disease

A

Immune mediated systemic disorder elicited by
gluten in genetically susceptible individuals
* Characterized by the presence of
*variable combination of gluten-dependent clinical manifestations,
*CD specific antibodies,
*HLA-DQ2 and HLA-DQ8 haplotype, and *enteropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

patients at increased risk of celiac disease

A
  • T1DM,
  • Down sy,
  • Turner sy,
  • Williams sy,
  • autoimmune thyroid disease,
  • selective IgA deficiency,
  • autoimmune liver disease,
  • first relatives with CD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

Symptoms of celiac disease

A
  • Chronic abdominal pain, distension
  • Chronic fatigue
  • Failure to thrive, weight loss, stunted growth
  • Iron-deficiency anemia
  • Dermatitis herpetiformis rash (Duhring disease)
  • Diarrhea, obstipation
  • Delayed puberty, amenorrhea
  • Nausea, vomiting
  • Recurrent aphthosus stomatitis
  • Abnormal live biochemistry
  • Osteoporosis, osteopenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

diagnosis of celiac disease steps

A
  1. Clinical suspicion of CD or risk group for CD? yes
  2. Measure transglutaminase antibodies (TGA-IgA) & total IgA, positive
    *If negative —> esophagogastroduodenoscopy for biopsies from distal duodenum
  3. Test for endomysial antibodies (EMA-IgA), positive
    *If negative —> esophagogastroduodenoscopy for biopsies from distal duodenum .
  4. CONFIRMED CD
    *Biopsy is not done unless necessary in children
    Taken from distal duodenum (min 4x) and duodenal bulb (min 1x) ‣
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

histology of celiac disease

A

Histology:
* villous atrophy,
* elongated crypts,
* increased intraepithelial lining density,
* increased intraepithelial lining mitotic index,
* infiltration of plasma cells + lymphocytes + mast cells into lamina propria
*
Diagnosis without biopsy if anti-TAG titer >10x upper limit + symptoms + EMA positivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

diagnosis without a biopsy in celiac disease if

A

Diagnosis without biopsy if
anti-TAG titer >10x upper limit
+ symptoms
+ + EMA positivity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

treatment of celiac disease

A

GLUTEN-FREE DIET

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

NOT allowed food in celiac disease

A

Not allowed:
* wheat,
* barley,
* bulgur,
* cuscus,
* malt,
* normal beer,
* cans,
* instant coffee

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

long term complication of celiac disease

A
  • Lymphoma,
  • esophageal carcinoma,
  • ulcerative jejunitis,
  • other autoimmune diseases,
  • cardiomyopathy,
  • infertility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

Cholestatic liver disease

A

Impaired bile flow —> accumulation in liver and serum of substances that normally are secreted in the bile:
* bilirubin,
* bile acids,
* cholesterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Cholestatic liver disease most recognizable laboratory manifestation

A

Hyperbilirubinemia is the most recognizable laboratory manifestation of cholestasis
◦Direct/conjugated bilirubin > 40 micromol/l and/or > 15-20% of total bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

bilirubin level in cholestasis
is it conjugated or unconjugated?

A

◦Direct/conjugated bilirubin > 40 micromol/l

and/or > 15-20% of total bilirubin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Cholestasis etiology

A

intrahepatic vs extrahepatic
* Biliary atresia
* Alagille syndrome
* Alpha-1 antitrypsin deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Biliary atresia is it common in infants?

A

Uncommon disease in infants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Biliary atresia
what is it

A

Closed/discontinuous biliary tracts

  • Destructive, obliterative cholangiopathy that affects both intra- and extrahepatic bile ducts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

biliary atresia complications

A

if left untreated —> early liver cirrhosis (at approx. 9 weeks of age),
may die within first 2 years of life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Forms of biliary atresia:

A
  • Congenital/syndromic/fetal/embryonic type (10%)
  • Postnatal/non-syndromic/perinatal type (90%)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

Congenital/syndromic/fetal/embryonic type of biliary atresia

A

10% of biliary atresia
* Associated with anatomical anomalies in 10-20%
* Part of biliary atresia splenic malformation (BASM) syndrome:
*asplenia/polysplenia
*abnormal abdominal situs,
*intestinal malrotation,
*abdominal vascular anomalies,
*congenital heart disease,
*pancreatic malformations
Bad prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

Congenital/syndromic/fetal/embryonic type of biliary atresia

A

Bad prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

biliary atresia splenic malformation (BASM) syndrome

A

Congenital/syndromic/fetal/embryonic type of biliary atresia is part of it

  • asplenia/polysplenia
  • abnormal abdominal situs
  • intestinal malrotation
  • abdominal vascular anomalies
  • congenital heart disease
  • pancreatic malformations
87
Q

Postnatal/non-syndromic/perinatal type of biliary atresia

A

90% of biliary atresias
Not associated with anatomical
malformations

88
Q

biliary atresia clinical presentation

A
  • Prolonged icterus/jaundice
  • Acholic stool (clay-colored, lacking bile pigment)
  • dark urine
  • Hepatomegaly
  • Bleeding (from disturbed coagulatory protein production)
  • Portal hypertension
  • Cirrhosis
89
Q

biliary atresia diagnosis laboratory

A

Direct serum bilirubin↑
transaminase↑
ALP↑
GGT ↑
Synthetic dysfunction —> coagulopathy, hypoalbuminemia

90
Q

imaging in biliary atresia

A
  • US: small and absent gallbladder, no bile duct dilation, malformations
    Done after 4-6h of fasting
  • Liver biopsy: active inflammation with bile duct degeneration and fibrosis, bile duct
    proliferation, portal stromal edema
  • Hepatobiliary scintiscanning (HBSS) (scintigraphy): failed excretion of the tracer into the bowel
  • Intraoperative cholangiography: confirms diagnosis
91
Q

what confirms diagnosis of biliary atresia

A

Intraoperative cholangiography:

92
Q

biliary atresia treatment

A
  • Kasai procedure (hepatoportoenterostomy): connection is created between the liver and the small intestines to allow for bile drainage
  • Liver transplantation: in case of liver cirrhosis
93
Q

Alagille syndrome

A
  • Uncommon genetic condition characterized by intrahepatic biliary duct aplasia or hypoplasia
  • Autosomal dominant inheritance of mutation in the JAG1 gene
94
Q

Alagille syndrome clinical presentation

A
  • Hepatic manifestations: cholestasis, jaundice, pruritus, cirrhosis
  • Facial dysmorphism: triangular face,
    deep set eyes, broad nasal bridge
    Congenital heart defects (eg peripheral pulmonary stenosis)
  • Butterfly vertebrae
  • Posterior embryotoxon (thickening of
    Schwalbe’s ring in cornea)
  • Renal dysplasia
95
Q

Alagille syndrome diagnosis - major criteria

A

5 major criteria: 3 is needed (interlobular bile duct atresia + 2)
* Interlobular bile duct absence/cholestasis
* Cardiac malformation/insufficiency
* Spine deformity
* Characteristic face
* Ocular abnormality

Confirmation via genetic testing (JAG1 gene mutation

96
Q

Confirmation of alagille syndrome

A

via genetic testing (JAG1 gene mutation

97
Q

Alagille syndrome treatment

A
  • Depends on affected organ
  • Conservative treatment of cholestasis and pruritus (eg ursodeoxycholic acid, cholestyramine )
98
Q

Alpha-1 antitrypsin deficiency

A

Genetic disorder characterized by the accumulation of defective alpha-1 antitrypsin enzyme

99
Q

mutation in alpha 1 antitrypsin deficiency

severity of disease depends on ?

A

Caused by mutation in the SERPINA1 gene,
the severity of the disease depends on the specific genotyping expression
which correlates with the amount of alpha1-antitrypsin synthesis

100
Q

Alpha-1 antitrypsin deficiency pathophysiology

A
  • Alpha-1 antitrypsin is a protease inhibitor that is synthesized in the liver and protects cells from breakdown by neutrophil elastase (protease)
  • Gene mutation induces a conformational change in the structure of AAT —dysfunctional (or absent) AAT
  • Effect on liver: accumulation of faulty AAT in hepatocellular endoplasmic reticulum —>
    hepatocyte destruction —> hepatitis and liver cirrhosis
    Effect on lungs: deficient AAT —> uninhibited protease activity —> destruction of pulmonary parenchyma —> panacinar emphysema (differ from centrilobular emphysema from smoking)
101
Q

Alpha-1 antitrypsin deficiency clinical presentation

A
  • Pulmonary manifestations: cough, wheezing, dyspnea, diminished breath sounds, barrel chest
  • Hepatic manifestations: prolonged neonatal jaundice, hepatitis, cirrhosis, increased risk of
    HCC
102
Q

Alpha-1 antitrypsin deficiency diagnosis

A
  • Serum: decreased AAT
  • Electrophoresis: decreased alpha 1 peak
  • Chest x-ray: low + flat diaphragm, widened intercostal spaces, hyperinflation and increased basilar radiolucency on both lungs
  • Chest CT: paracinar emphysema, bronchiectasis, bullae
  • Liver biopsy: PAS-positive, spherical inclusion bodies (accumulated proteins) in periportal
    hepatocytes, signs of cirrhosis
103
Q

Alpha-1 antitrypsin deficiency treatment

A
  • General measures: ‣Avoid active and passive smoking, preventative vaccination (eg influenza)
  • Symptomatic treatment: ‣Bronchodilators, pulmonary rehabilitation, nutritional support
  • Antitrypsin replacement: ‣In patients with severe AAT deficiency
  • Liver transplantation: ‣Considered for end-stage liver disease
104
Q
  1. Hepatitis in childhood
A
  • Viral hepatitis
  • Non-alcoholic fatty liver disease (NAFLD)
  • Autoimmune hepatitis (AIH)
105
Q

Viral hepatitis pathogens

A

Hepatitis A —> fecal-oral transmission
Hepatitis B —> blood/sexual transmission
Hepatitis C —> blood/sexual transmission

106
Q

symptoms of viral hepatitis

A
  • Fever,
  • fatigue,
  • malaise,
  • anorexia,
  • nausea,
  • arthralgia,
  • RUQ pain, jaundice +/- hepatomegaly
  • splenomegaly
  • adenoma they
  • urticaria
107
Q

diagnosis of viral hepatitis

A
  • Increased liver enzymes: ◦ ↑ALT, ↑AST, ↑GGT, ↑ALP
  • Viral serology (IgM antibodies), viral PCR, blood culture
108
Q

treatment of viral hepatitis

A

usually self-limiting *
Unless immunocompromised —> no antivirals ◦If fulminant hepatitis —> ICU transfer, liver transplantation

109
Q

what to do in case of fulminant hepatitis

A

—> ICU transfer, liver transplantation

110
Q

what is fulminant hepatitis

A

clinical syndrome of severe liver function impairment, which causes
hepatic coma and
the decrease in synthesizing capacity of liver, and
develops within eight weeks of the onset of hepatitis.

111
Q

complications of viral hepatitis

A

Chronic hepatitis (especially HCV), hepatocellular carcinoma,
cirrhosis

112
Q

preventive measure against viral hepatitis

A

Hepatitis A + B vaccination

113
Q

Recommendations for hepatitis B immunization what ages

A

Active immunization is recommended for all infants in three doses:
At birth
At 1–2 months
At 6–18 months
Infants weighing < 2,000 g: Administer the first dose at 1 month of age or at hospital discharge (whichever is earlier).

114
Q

Non-alcoholic fatty liver disease (NAFLD)
what is it
epidemiology

A

More than 5% fatty transformation of hepatocytes in liver biopsy (macrovesicular)

Epidemiology:
7,6% in general population,
34% in obese children
One of the most common causes of chronic liver disease in young people in the developed world

115
Q

One of the most common causes of chronic liver disease in young people in the developed world

A

NAFLD

116
Q

NAFLD Pathogenesis

A

increased insulin resistance —> *
↑Hepatic uptake of fatty acids ◦
↑Triglyceride synthesis ◦
↑Peripheral lipolysis

117
Q

clinical presentation of NAFLD

A

Non-alcoholic steatohepatitis (NASH)
Fibrosis, cirrhosis
Hepatocellular carcinoma
Obesity

118
Q

DIAGNOSIS of NAFLD

A
  • Ultrasound: low sensitivity
  • MRI
  • Fibroscan: transient elastography
  • Biopsy: to exclude other treatable diseases before starting drug or surgical treatment, last step in diagnosis
119
Q

What do we have to exclude when diagnosing NAFLD

A

Need to exclude:
* excessive alcohol consumption,
* viral infections,
* autoimmune liver injury,
* drug induced liver injury (DILI)
* malabsorption,
* metabolic diseases (eg Wilson disease, fructosemia)

120
Q

Treatment of NAFLD

A

few efficient ones in pediatrics

  • Vitamin E (conflicting results)
  • Docosahexaenoic acid (DHA) (encouraging results)
  • Probiotics (potential effect)

Insulin sensitisers (not recommended)
Statins (only in adults)

121
Q

Autoimmune hepatitis (AIH)

A

Rare form of chronic hepatitis that predominantly affects girls

122
Q

Autoimmune hepatitis is associated with

A

Commonly associated with
other autoimmune disorders (eg type 1 DM, celiac disease

123
Q

Types of autoimmune hepatitis

A
  • Autoimmune hepatitis type 1 *(80%): characteristic ANAs, ASMAs, anti-soluble liver antigen Abs
  • Autoimmune hepatitis type 2: characteristic anti-liver-kidney microsomal Abs, anti-liver cytosol Abs **
  • Seronegative autoimmune hepatitis/ hepatitis associated aplastic anemia (HAA) **
  • Giant cell hepatitis with autoimmune hemolytic anemia **
  • De novo -alloimmune- hepatitis post liver transplantation
124
Q

autoimmune hepatitis type 1

A

(80%):
characteristic
ANAs,
ASMAs,
anti-soluble liver antigen Abs

125
Q

Autoimmune hepatitis type 2

A

characteristic
anti-liver-kidney microsomal Abs,
anti-liver cytosol Abs

126
Q

symptoms of autoimmune hepatitis

A
  • Non-specific symptoms:
    *fatigue,
    *upper abdominal pain,
    *weight loss
  • Signs of acute liver failure:
    *jaundice,
    *RUQ pain,
    *fever,
    *hepatomegaly,
    *splenomegaly,
    *ascites
127
Q

diagnosis
lab values of autoimmune hepatitis

A

◦Lab
* ↑↑ALT, ↑AST, ↑GGT, ↑ALP
* Serum antibodies
* Serum protein electrophoresis: hypergammaglobulinemia (↑IgG)
* Normochromic anemia,
* thrombocytopenia,
* mild leukoplakia,
* ↑ESR

128
Q

diagnosis of autoimmune hepatitis -other than labs

A

Liver biopsy
* Biopsy should be performed following the detection of AIH antibodies to confirm the diagnosis
—> findings:
lymphoplasmacytic interface hepatitis (ongoing inflammatory process with
*lymphocytic infiltration,
*necrosis,
*fibrotic changes,
*bile duct changes)

129
Q

treatment of autoimmune hepatitis

A
  • Immunosuppressive medications ◦
    Induction therapy** ‣
    1st line: prednisone with or without azathioprine *
    2nd line: mycophenolate, cyclosporine, tacrolimus *
    **
    Maintenance therapy
    : low doses of azathioprine or prednisone ‣
  • Liver cirrhosis treatment > Liver transplantation
130
Q

autoimmune hepatitis induction therapy

A

1st line:
*prednisone with or without azathioprine

2nd line:
*mycophenolate,
*cyclosporine,
*tacrolimus

131
Q

autoimmune hepatitis maintenance therapy

A

low doses of azathioprine or prednisone

132
Q

treatment of liver cirrhosis

A

Liver transplantation

133
Q

Most common infectious enteritises

A

Infectious gastroenteritis
* Viral gastroenteritis
* bacterial enteritis

134
Q

Most common diarrheal disorder

A

Infectious gastroenteritis-
Viral gastroenteritis

Can occur throughout the year, but peak during fall-winter period

135
Q

what time of year does viral gastroenteritis peaks

A

Can occur throughout the year, but peak during fall-winter period

136
Q

transmission of viral gastroenteritis

A
  • oral-fecal contamination,
  • possible airborne transmission of Rotavirus + Norovirus
  • contaminated food and water
137
Q

viral gastroenteritis common symptoms

A
  • non-bloody diarrhea,
  • vomiting, fever,
  • abdominal pain,
  • anorexia,
  • headache,
  • myalgia
138
Q

uncommon symptoms of infectious viral gastroenteritis

A

gross blood or mucus in the stool —> consider bacterial etiology

139
Q

diagnosis of viral gastroenteritis

A
  • Diagnosis: clinically, stool testing is typically not necessary in viral infections
  • Precise etiology is only required in *outbreaks,
    *patient isolation,
    *immunocompromised patients
    diarrhea lasting >7 days

uncertain diagnosis —> done with PCR, ELISA, latex agglutination

140
Q

precise etiology of viral gastroenteritis is required only in ?

A
  • Precise etiology is only required in *outbreaks,
    *patient isolation,
    *immunocompromised patients
    diarrhea lasting >7 days
141
Q

uncertain diagnosis of viral gastroenteritis is done by

A

—> done with
PCR,
ELISA,
latex agglutination

142
Q

pathogenesis of viral gastroenteritis

A

intestinal infection —> destruction of enterocytes —> transudation of fluid into
intestinal lumen —> diarrhea —>
net loss of fluid and salt + decreased ability to digest food and absorb its components

143
Q

common pathogens in infectious gastroenteritis depending on time of year

A
  • Fall-winter:
    *Rotavirus (6 months-2 years)
    *Astrovirus (<4 years)
  • All around the year:
    *Norovirus (all ages, highly contagious, can cause outbreaks)
    *Sapovirus (infants/toddlers, milder than Rotavirus enteritis)
144
Q

which is milder viral enteritis

A

Sapovirus (infants/toddlers, milder than Rotavirus enteritis)

145
Q

what virus can cause outbreaks of viral gastroenteritis

A

norovirus
highly contagious

146
Q

complications of viral gastroenteritis

A
  • hypovolemia/dehydration
  • electrolyte imbalance
  • carbohydrate intolerance
  • irritant diaper dermatitis
  • CNS symptoms (seizures)
147
Q

treatment of viral gastroenteritis

A

fluid resuscitation

148
Q

preventitive measures against viral gastroenteritis

A
  • contact precaution,
  • hand hygiene,
  • environmental cleaning
149
Q

Bacterial enteritis is typical in what age

A

Typically in patients > 2 years

150
Q

transmission of bacterial enteritis

A
  • oral-fecal contamination
  • exposure to poultry/farm animals/contaminated meat
151
Q

symptoms of bacterial enteritis

A

high fever,
tenesmus (s a frequent urge to go to the bathroom without being able to go. )
severe abdominal pain,
gross blood or mucus in the stool

152
Q

diagnosis of bacterial enteritis

A
  • stool culture
  • PCR for some bacteria (Campylobacter, Shigella)
153
Q

what bacteria do we use PCR for in bacterial enteritis

A

Campylobacter, Shigella

154
Q

common pathogens in bacterial enteritis

A
  • Shiga-toxin producing E. Coli (STEC),
  • Salmonella
  • Shigella
  • Clostridium difficile
  • Campylobacter Jejuni
  • Yersinia enterocolitica
155
Q

complications of bacterial enteritis

A
  • sepsis
  • peritonitis
  • rash
  • arthritis
  • Guilaine-Barré syndrome (Campylobacter)
  • CNS symptoms (seizures, encephalopathy)
  • hemolytic uremic syndrome (Shigella, STEC)
156
Q

treatment of bacterial enteritis

A

fluid resuscitation,
antibiotics (in case of severe illness, young patients)

157
Q

antibiotic of choice in salmonella gastroenteritis

A

Salmonella gastroenteritis —>
* Fluoroquinolones
* TMP-SMX
* Azithromycin
* 2nd/3rd gen cephalosporins
AB does not shorten duration of carriage (approx. 5 weeks)

158
Q

antibiotic of choice in camplybacter jejuni bacterial enteritis

A

Campylobacter jejuni —>
* Azithromycin,
* Fluoroquinolones

159
Q

antibiotic of choice in shigella bacterial enteritis

A

Ceftriaxone,
Ciprofloxacin,
Azithromycin

160
Q

therapy of choice in shiga toxin producing e.coli (STEC) bacterial enteritis

A

antibiotics are NOT recommended, only give fluids

161
Q

Oral rehydration therapy (ORT) in bacterial enteritis

A

Less glucose + Na —> lower osmolar activity —> reduced stool volume and shorter
duration of diarrhea

1) rehydration phase: frequent small boluses
2) maintenance phase: after each diarrhea
(10ml/kg) + vomit (2ml/kg)

Switch to IV fluids if: severe dehydration, altered mental status, risk of aspiration, limited *
intestinal capacity, excessive stool output and no improvement with ORT, persistent vomiting resulting in inadequate intake of ORT

162
Q

when to switch to IV fluids instead of ORT in bacterial enteritis

A

Switch to IV fluids if:
* severe dehydration,
* altered mental status
* risk of aspiration,
* limited intestinal capacity
* excessive stool output
* and no improvement with ORT
* persistent vomiting resulting in inadequate intake of ORT

163
Q

inflammatory bowel diseases

A

Ulcerative colitis (UC) or Crohn’s disease

164
Q

Incidence of IBD in childhood

A

in childhood is 7,5/100.000

165
Q

which is more common UC or CD

A

Crohn’s disease is 2x more common

166
Q

IBD risk factors for infants

A
  • Antibiotic administration
  • smoking
  • lack of breastfeeding
  • familial IBD (2-8x higher risk if parent has IBD)
  • Breast milk reduces incidence of CD by
    33% and UC by 23%
167
Q

crohns disease wall involvement

A

transmural, with knife-like fissures

168
Q

location of crohns disease

A

anywhere from mouth —> anus with skip lesions, terminal ileum is the most common

169
Q

symptoms of crohns disease

A
  • right lower quadrant pain (ileum)
  • with non-bloody diarrhea,
  • weight loss, appetite loss
170
Q

histology of crohns

A

lymphoid aggregates with granulomas

171
Q

gross appearance of crohns disease

A
  • cobblestone mucosa (from healing process)
  • creeping fat (fat pulled up by myofibroblast contractions of granulation tissue)
  • strictures (extreme narrowing of bowel lumen) —> “string” sign
172
Q

complication of crohns disease

A
  • malabsorption with nutritional deficiency
  • calcium oxalate nephrolithiasis
  • fistula formation
  • carcinoma
173
Q

Ulcerative colitis (UC) wall involvement

A

mucosal + submucosal

174
Q

UC localization

A

ONLY colon, begins in rectum —> spreads proximal up to cecum (continuous/segmental)

1st: proctitis —>
2nd: proctosigmoiditis (“left-side colitis”) —> 3rd: extensive colitis —>
4th: ‣pancolitis

175
Q

UC symptoms

A
  • left lower quadrant pain (rectum)
  • bloody diarrhea
  • increased number of stool
  • mucus in stool
  • urgency
  • fecal incontinence
  • 25% experience obstipation
  • tenesmus (feeling of fecal residue)
176
Q

UC histo

A

crypt abscesses with neutrophils

177
Q

Gross appearance of UC

A
  • psedupolyps (two necrotic areas of close proximity form “polyp” btw)
  • loss of haustra due to extensive inflammation —> “lead-pipe” sign
178
Q

complications of UC

A

toxic megacolon (massive dilation with rupture risk)
carcinoma

179
Q

what protects against UC

A

smoking
appendectomy

180
Q

Extraintestinal manifestations: of IBD
and are they common?

A

more common in childhood (30% experience them
* Eye symptoms: uveitis, episcleritis, keratopathy
* Skin symptoms: erythema nodosum, pyoderma gangrenosum, metastatic Crohn’s disease (skin lesions in areas not connected to GI tract)
* Joint symptoms: arthritis, sacroileitis
* Other: fever, growth retardation, delayed puberty, hepatitis, pancreatitis

181
Q

diagnosis of CD

A
  • Stool culture :
    *Yersinia
    *TBC
  • Laboratory
    *albumin
    *ASCA (auto-antibodies)
    *CRP, PLT, Iron
  • Imaging
    *Abdominal US: intestinal wall thickening
    *MR enterography: determine which bowel ‣segment is involved
  • Endoscopy CD: granuloma
182
Q

what imaging method used to determine segment involvement in IBD

A

MR enterography: determine which bowel ‣
segment is involved

183
Q

diagnosis of UC

A
  • Stool culture UC:
    *Shigella
    *salmonella
    *campylobacter
    *EHEC (enterohemorrhagic E. coli )
    *Clostridium
  • laboratory :
    *ANCA (auto-antibodies)
    *Both: CRP, platelets, iron
  • Imaging
    *Abdominal US: intestinal wall thickening ‣
    *MR enterography: determine which bowel ‣
    segment is involved
  • Endoscopy UC: cryptabscesses
184
Q

induction therapy of CD

A

Induction therapy CD:
* exclusive enteral nutrition (EEN):
*nasogastric tube insertion and
*strict formula-based (no-solid-food) diet for 6-8 weeks

More efficient than steroids, and no side effects
Same efficacy as biological therapy

185
Q

maintenance therapy in CD

A

CD:
* partial enteral nutrition (PEN),
* immunomodulators (AZT/MTX)

186
Q

relapse therapy in CD

A

CD:
EEN exclusive enteral nutrition

187
Q

induction therapy in UC

A
  • anti-inflammatory (5-ASA: aminosalicylate)
  • steroids
188
Q

maintenance therapy UC

A

anti-inflammatory (5-ASA), immunomodulators

189
Q

relapse therapy UC

A

steroids

190
Q

Rescue therapy in IBD

A

Both:
biological treatment,
surgery:
CD: only for a small section if possible —> ileocecal resection w/ diversion stoma

UC: colon removal is definite —> total colectomy w/ pouch preparation

191
Q

biological theraoy in IBD

A

as rescue therapy

Biologicals are extracted from or produced by a biological source
Types‣ :
* TNFalpha inhibitors:
*Infliximab
*Adalimumab
* Integrin inibitor: Vedolizumab
* Anti-IL12/23 antibody: Ustekinumab
* JAK inhibitors: Tofacitinib

192
Q

Alarming signs of acute abdominal diseases & differential diagnosis

A
  • Ileus:
    *constipation,
    *vomiting
    *delayed passing of meconium
  • Appendicitis:
    *strong pain in McBurney point/periumbilical, *Cullen sign
    *Grey-Turner sign
    *defense
    *vomiting
    *fever
  • Pancreatitis: belt-like pain radiating to back, rebound tenderness
  • Perforated bowels: free abdominal air = decreased dullness over liver
  • NEC [preterm infants]:
    *feeding intolerance
    *bloody stool
    *distended abdomen
    *vomiting, diarrhea
    *sepsis-like symptoms
  • Trauma
  • Ectopic pregnancy
  • Ovarian torsion:
    *sudden-onset unilateral abdominal/pelvic pain,
    *nausea/vomiting
    *adnexal mass may be palpable
  • Internal bleeding: *hematemesis/hematochesia/melena, *hypovolemia, shock, anemia
  • Pyloric stenosis [2-7 weeks, usually boys]: *vomiting after feeding
    *palpable olive-shaped mass in epigastrium, *“hungry vomiter”
    *dehydration,
    *weight loss, failure to thrive
  • Cholecystitis: Murphy sign
  • Intussusception [usually <5 years]:
    *currant jelly bloody stool
    *pain is coming and going (periodic), *retraction in RLQ
    *high-pitched bowel sounds on auscultation
  • Volvulus: bilious vomiting, abdominal distension, abdominal pain, inability to pass NG tube *
  • Bowel ischemia:
    *hematochesia, hematemesis
    *hypotension, tachycardia, shock
193
Q

Neonatal jaundice bilirubin level

A
  • One of the most common conditions occurring in newborns and infants
  • Characterized by elevated levels of bilirubin in the blood
    Total serum bilirubin concentration > 5 mg/dL (normal: 0,1-1,2 mg/dL)
194
Q

Classification of neonatal jaundice

A

physiological or pathological

195
Q

Physiological neonatal jaundice
- type of hyperalbuminemia
- onset
- peak total serum bilirubin
- daily rise in bilirubin

A
  • type of hyperalbuminemia: always conjugated
  • onset > 24 hours after birth
  • peak total serum bilirubin: <15mg/dl (if full term, breast fed)
  • daily rise in bilirubin <5mg/dl/day
196
Q

pathological neonatal jaundice
- type of hyperalbuminemia
- onset
- peak total serum bilirubin
- daily rise in bilirubin

A
  • type of hyperalbuminemia: conjugated or Unconjugated
  • onset: can be present <24hrs after birth
  • peak total serum bilirubin > 15 mg/dl
  • daily rise in bilirubin < 5mg/dl
197
Q

etiology of physiological jaundice

A

hemolysis of fetal hemoglobin and an immature hepatic metabolism of bilirubin

198
Q

etiology of pathological unconjugated jaundice

A
  • Hemolytic: increased production of bilirubin
  • Non-hemolytic: *
    *Decreased conjugation of bilirubin
    Gilbert syndrome,
    Crigler-Najjar syndrome,
    Hypothyroidism
    *Decreased stool passage —> increased enterohepatic circulation of bilirubin ◦
    GI obstruction,
    Hirschsprung disease,
    cystic fibrosis,
    breastfeeding jaundice
199
Q

pathological unconjugated hyperbilirubinemia-
Hemolytic causes

A

*ABO or Rh incompatibility
*erythrocyte enzyme defect (G6PD deficiency),
*hemoglobinopathies (sickle cell anemia), *hematomas (vacuum-assisted delivery), *infection/sepsis,
*polycythemia

200
Q

non hemolytic causes of pathological unconjugated hyperbilirubinemia

A

Non-hemolytic: *
* Decreased conjugation of bilirubin ◦
*Gilbert syndrome,
*Crigler-Najjar syndrome,
*Hypothyroidism ‣
* Decreased stool passage —> increased enterohepatic circulation of bilirubin ◦
*GI obstruction,
*Hirschsprung disease,
*cystic fibrosis,
*breastfeeding jaundice

201
Q

Pathological conjugated hyperbilirubinemia classification

A
  • intra hepatic
    *decreased hepatic uptake of bilirubin
    decreased excretion of bilirubin
  • extra hepatic
202
Q

Pathological conjugated hyperbilirubinemia ‣
Intrahepatic

A
  • Decreased hepatic uptake of bilirubin
    *Rotor syndrome
  • Decreased excretion of bilirubin ◦
    *Alagille syndrome,
    *TORCH infections,
    *Dubin-Johnson syndrome,
    *sepsis (MOF
203
Q

Pathological conjugated hyperbilirubinemia
extrahepatic causes

A

Extrahepatic *
* Decreased excretion of bilirubin ◦
*Biliary atresia
*biliary/choledochal cyst,
*tumors/strictures

204
Q

Mixed hyperbilirubinemia ‣

A

Hepatitis, cirrhosis

205
Q

diagnosis of neonatal jaundice

A
  • Physical finding of icterus/jaundice
  • Bilirubin tests:
    *total serum bilirubin
    *differentiation of direct (conjugated) and indirect (unconjugated) bilirubin
  • Other lab tests:
    *CBC (including reticulocyte count),
    *blood group,
    *direct + indirect Coombs test (for ◦
    Rh incompatibility),
    *inflammatory markers,
    *liver enzymes,
    *total serum protein and albumin,
    *TSH,
    *G6PD activity
206
Q

treatment of neonatal jaundice

A
  • Phototherapy: primary treatment in neonates with unconjugated hyperbilirubinemia
  • Exchange transfusion: most rapid method for lowering bilirubin concentrations
    *Use ABO-matched and Rh-negative erythrocyte concentrate and exchange blood via ‣umbilical venous catheter
  • IV immunoglobulins: in cases with immunologically mediated conditions or in presence of Rh,
    *ABO or other blood group incompatibilities that cause jaundice
207
Q

phototherapy in neonatal jaundice

A

Exposure to blue light —> photoisomerization (major mechanism) and photooxidation (minor mechanism) of unconjugated (hydrophobic) bilirubin in skin to water-soluble form that can be excreted through urine and/or bile
Adequate fluid supplementation to prevent dehydration + eye protection to prevent damage

208
Q

contraindication of phototherapy in neonatal jaundice

A

congenital erythropoietin porphyria (severe photosensitivity)

209
Q

side effects of phototherapy

A

Side effects:
* diarrhea,
* dehydration,
* changes in skin hue (bronzing),
* separation of neonate from mother,
* increased risk of AML

210
Q

indications of Exchange transfusion

A
  • inadequate response to phototherapy or rapid rise in bilirubin level,
  • acute bilirubin encephalopathy,
  • hemolytic disease,
  • severe anemia
211
Q

exchange tranfusion side effect

A

higher mortality and morbidity from infections,
acidosis,
thrombosis,
hypotension,
electrolyte imbalance

212
Q

IV immunoglobulin is given in what

A

in cases with
* immunologically mediated conditions
* or in presence of Rh,
* ABO or other blood group incompatibilities that cause jaundice

213
Q

prevention of neonatal jaundice

A

adequate enteral nutrition —> frequent feeds with breast milk or other protein-rich nutritions